Janux Therapeutics, Inc.

JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001817713

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jun 4, 2026Jun 2, 2026Doyle Janeen NoelChief Corp. & Bus. Dev. OfcrSSaleCommon Stock−4.06K$14.03−$56.95K75.94K−5.1%SEC
May 13, 2026May 11, 2026Dobek MariaVice President, AccountingSSaleCommon Stock−2.04K$14.17−$28.88K32.27K−5.9%SEC
Jan 2, 2026Jan 2, 2026McIver ZachariahChief Medical OfficerSSaleCommon Stock−2.71K$13.73−$37.26K23.29K−10.4%SEC
Jan 2, 2026Jan 2, 2026Dobek MariaVice President, AccountingSSaleCommon Stock−1.46K$13.73−$20.07K15.37K−8.7%SEC
Jan 2, 2026Jan 2, 2026DiRaimondo ThomasChief Scientific OfficerSSaleCommon Stock−2.51K$13.73−$34.39K124.43K−2.0%SEC
Jan 2, 2026Jan 2, 2026Winter Charles M.Chief Technical OfficerSSaleCommon Stock−2.4K$13.73−$32.97K77.72K−3.0%SEC
Jan 2, 2026Jan 2, 2026Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−1.88K$13.73−$25.8K83.1K−2.2%SEC
Jan 2, 2026Jan 2, 2026Campbell David AlanPresident and CEOSSaleCommon Stock−8.07K$13.73−$110.83K284.98K−2.8%SEC
Dec 3, 2025Dec 1, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$32.9772−$109.91K84.97K−3.8%SEC10b5-1
Nov 14, 2025Nov 14, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$30.00−$99.99K84.97K−3.8%SEC10b5-1
Oct 30, 2025Oct 28, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−16.67K$30.06−$500.95K82.14K−16.9%SEC10b5-1
May 2, 2025May 1, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$32.028−$106.75K82.14K−3.9%SEC10b5-1
Apr 23, 2025Apr 21, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$30.00−$100.02K82.14K−3.9%SEC10b5-1
Mar 7, 20256:05 PM ETMar 5 – Mar 7, 2025RA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseCommon Stock+824.04K$30.7545+$25.34M10.14M+8.8%SEC
Mar 5, 2025Mar 3, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$32.1421−$107.16K82.14K−3.9%SEC10b5-1
Feb 5, 2025Feb 3, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−3.33K$42.2945−$141.01K82.14K−3.9%SEC10b5-1
Jan 8, 2025Jan 7, 2025Campbell David AlanPresident and CEOSSaleCommon Stock−5K$60.00−$300K293.05K−1.7%SEC10b5-1
Jan 3, 2025Jan 2, 2025Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−13.33K$54.8816−$731.79K82.14K−14.0%SEC
Dec 27, 2024Dec 24, 2024Campbell David AlanPresident and CEOSSaleCommon Stock−25K$56.19−$1.4M217.05K−10.3%SEC10b5-1
Dec 3, 2024Dec 3, 2024Campbell David AlanPresident and CEOSSaleCommon Stock−15K$67.00−$1.01M242.05K−5.8%SEC10b5-1
Nov 27, 2024Nov 25, 2024Campbell David AlanPresident and CEOSSaleCommon Stock−25K$51.5939−$1.29M257.05K−8.9%SEC10b5-1
Oct 30, 2024Oct 28, 2024Campbell David AlanPresident and CEOSSaleCommon Stock−25K$53.5398−$1.34M282.05K−8.1%SEC10b5-1
Oct 24, 2024Sep 13, 2024Lichter Jay10% OwnerSSaleCommon Stock−3.82K$46.68−$178.08K7K−35.3%SEC
Oct 22, 20244:20 PM ETOct 18, 2024RA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseCommon Stock+1.2M$44.75+$53.7M9.32M+14.8%SEC
Oct 18, 20246:51 PM ETOct 16 – Oct 18, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−762.47K$46.3443−$35.34M2.07M−26.9%SEC
Oct 18, 20246:51 PM ETOct 16 – Oct 18, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−910.66K$46.2701−$42.14M2.12M−30.1%SEC
Sep 30, 20248:49 PM ETSep 26 – Sep 30, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−140.49K$46.9489−$6.6M6.89K−95.3%SEC
Sep 30, 20248:49 PM ETSep 26 – Sep 27, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−167.29K$46.9639−$7.86M2.88M−5.5%SEC
Sep 27, 2024Sep 27, 2024Meyer Andrew HollmanChief Business OfficerSSaleCommon Stock−50K$45.96−$2.3M67.59K−42.5%SEC
Sep 27, 2024Sep 27, 2024DiRaimondo ThomasChief Scientific OfficerSSaleCommon Stock−5K$46.3464−$231.73K97.94K−4.9%SEC10b5-1
Sep 27, 2024Sep 27, 2024Campbell David AlanPresident and CEOSSaleCommon Stock−25K$46.3073−$1.16M307.05K−7.5%SEC10b5-1
Sep 12, 20248:42 PM ETSep 10 – Sep 12, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−203.68K$46.8943−$9.55M2.96M−6.4%SEC
Sep 12, 20248:42 PM ETSep 10 – Sep 12, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−247.42K$46.8944−$11.6M3.02M−7.6%SEC
Sep 10, 20245:02 PM ETSep 6 – Sep 9, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−110.55K$42.0065−$4.64M7K−94.0%SEC
Sep 10, 20245:02 PM ETSep 6, 2024Lichter Jay and 3 others10% OwnerSSaleCommon Stock−131.64K$42.00−$5.53M3.23M−3.9%SEC
Jun 5, 20247:19 PM ETJun 3, 2024Avalon Ventures XI, L.P. and 2 others10% OwnerSSaleCommon Stock−677.28K$54.75−$37.08M3.27M−17.2%SEC
Jun 5, 20247:19 PM ETJun 3, 2024Avalon Ventures XI, L.P. and 2 others10% OwnerSSaleCommon Stock−822.72K$54.75−$45.04M3.34M−19.8%SEC
Jun 5, 2024Jun 3, 2024Lichter JayDirector, 10% OwnerSSaleCommon Stock−1.5M$54.75−$82.13M3.34M−31.0%SEC
Jun 5, 2024Jun 3, 2024Reardon TigheActing Chief Financial OfficerSSaleCommon Stock−822.72K$54.75−$45.04M3.34M−19.8%SEC
Mar 6, 20244:15 PM ETMar 4, 2024RA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseCommon Stock · Derivative+1.4M$46.499+$65M1.4M–SEC
Nov 15, 2023Nov 13, 2023Reardon TigheActing Chief Financial OfficerPPurchaseCommon Stock+849.85K$5.87+$4.99M849.85KNew positionSEC
Nov 15, 2023Nov 13, 2023Lichter JayDirector, 10% OwnerPPurchaseCommon Stock+849.85K$5.87+$4.99M849.85KNew positionSEC
Nov 13, 20237:11 PM ETNov 13, 2023Avalon Ventures XI, L.P. and 2 others10% OwnerPPurchaseCommon Stock+849.85K$5.87+$4.99M849.85KNew positionSEC
Jul 21, 20234:31 PM ETJul 19, 2023RA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseCommon Stock+495.01K$12.46+$6.17M8.12M+6.5%SEC
Jul 21, 20234:31 PM ETJul 19, 2023RA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseCommon Stock · Derivative+503.23K$12.459+$6.27M503.23K–SEC
Dec 30, 20219:00 PM ETDec 29, 2021ORBIMED ADVISORS LLC and 2 othersDirectorSSaleCommon Stock−40.4K$20.30−$820.12K231.1K−14.9%SEC
Dec 30, 2021Dec 29, 2021Thompson Peter A.DirectorSSaleCommon Stock−40.4K$20.30−$820.12K231.1K−14.9%SEC
Dec 23, 20214:13 PM ETDec 21, 2021ORBIMED ADVISORS LLC and 2 othersDirectorSSaleCommon Stock−119.4K$19.00−$2.27M234.8K−33.7%SEC
Dec 23, 2021Dec 21, 2021Thompson Peter A.DirectorSSaleCommon Stock−119.4K$19.00−$2.27M234.8K−33.7%SEC
Dec 17, 20215:13 PM ETDec 16, 2021ORBIMED ADVISORS LLC and 2 othersDirectorSSaleCommon Stock−393.3K$19.07−$7.5M245.9K−61.5%SEC